Learners who wish to receive a certificate must register for the exam scheduled on April 17, 2026, which will be conducted in two sessions - 9:30 am to 12:30 pm and 2 pm to 5 pm ...

A chemotherapy-free combination treatment outperformed a combination of targeted therapy and chemotherapy among patients with Ph+ acute lymphoblastic leukemia (ALL) in a new study. The Phase III trial ...

A chemotherapy-free combination treatment outperformed a combination of targeted therapy and chemotherapy among patients with ...

Sacituzumab does not improve outcomes vs chemotherapy when used as the first treatment after endocrine therapy failure in HR+/HER2- advanced breast cancer, the ASCENT-07 trial finds.

Tennessee football recruits will sign contracts to receive money from the school under a salary cap. Knox News got an inside ...

Discusses SCOPE Phase II Data: iSCIB1+ Shows Improved Progression-Free Survival in Advanced Melanoma December 11, 2025 9:00 ...

Half a year has passed since U.S. immigration officials gave former Milwaukee teacher's aide Yessenia Ruano no choice but to ...

Combined androgen blockade shows significant survival benefits over single-agent ADT in high-risk prostate cancer, as ...

Patients with hormone receptor (HR)-positive, HER2-negative advanced breast cancers had similar progression-free survival (PFS) whether they were treated with sacituzumab govitecan-hziy (Trodelvy) or ...

A chemotherapy-free regimen significantly improved outcomes compared with standard therapy for newly diagnosed Ph+ acute ...

Kenna Wollard's breakout has her among the best players in college volleyball. Her journey, though, wasn't without challenges ...